Drug:
Reaction: DRUG DOSE OMISSION BY DEVICE
20260101 - 20261231
No. 1301 - 1400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1301 | 26296513 |
US |
7 | 2 |
Drug dose omission by device, Device issue, |
||||
SOMATROPIN, SOMATROPIN, SOMATROPIN, |
||||
| 1302 | 26296514 |
KR |
10 | 1 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1303 | 26296515 |
CO |
1 | |
Device leakage, Device physical property issue, Device connection issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1304 | 26296517 |
CO |
2 | |
Patient-device interaction issue, Device delivery system issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1305 | 26296524 |
US |
||
Bronchitis, Asthma, Drug dose omission by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1306 | 26296527 |
US |
52 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 1307 | 26296534 |
US |
13 | 2 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1308 | 26296538 |
JP |
1 | |
Drug dose omission by device, Device information output issue, Device mechanical issue, Device use issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 1309 | 26296543 |
PA |
15 | 1 |
Drug dose omission by device, Device use issue, Device information output issue, Device power source issue, |
||||
SOMATROPIN, |
||||
| 1310 | 26296549 |
AR |
7 | 2 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 1311 | 26296550 |
CO |
75 | 2 |
Device malfunction, Drug dose omission by device, |
||||
ETANERCEPT, |
||||
| 1312 | 26296557 |
US |
39 | 1 |
Blood glucose abnormal, Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, SOMATROPIN, TIRZEPATIDE, |
||||
| 1313 | 26296559 |
KR |
12 | 2 |
Drug dose omission by device, Device power source issue, Device information output issue, |
||||
SOMATROPIN, |
||||
| 1314 | 26296563 |
CO |
2 | |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1315 | 26296564 |
GB |
1 | |
Drug dose omission by device, Device power source issue, |
||||
SOMATROPIN, |
||||
| 1316 | 26296565 |
KR |
13 | 1 |
Drug dose omission by device, Device mechanical issue, Device breakage, |
||||
SOMATROPIN, |
||||
| 1317 | 26296566 |
US |
13 | 1 |
Drug dose omission by device, Device breakage, Device difficult to use, |
||||
SOMATROPIN, |
||||
| 1318 | 26296589 |
GB |
74 | 2 |
Device information output issue, Device power source issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1319 | 26296591 |
DO |
6 | 1 |
Device deposit issue, Device physical property issue, Device delivery system issue, Product packaging quantity issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1320 | 26296593 |
CO |
1 | |
Drug dose omission by device, Device breakage, Product communication issue, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 1321 | 26296597 |
US |
8 | 2 |
Drug dose omission by device, Device issue, |
||||
SOMATROPIN, |
||||
| 1322 | 26296598 |
CO |
1 | |
Drug dose omission by device, Device mechanical issue, |
||||
SOMATROPIN, |
||||
| 1323 | 26296599 |
CO |
2 | |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 1324 | 26296604 |
US |
7 | 1 |
Drug dose omission by device, Device information output issue, Device use error, Device breakage, Device mechanical issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 1325 | 26296781 |
US |
16 | 1 |
Drug dose omission by device, Device defective, |
||||
MARSTACIMAB-HNCQ, MARSTACIMAB-HNCQ, |
||||
| 1326 | 26296783 |
EU |
15 | 2 |
Device issue, Device leakage, Drug dose omission by device, |
||||
ETANERCEPT, |
||||
| 1327 | 26296784 |
GB |
71 | 2 |
Drug dose omission by device, Device mechanical issue, Device material issue, |
||||
DALTEPARIN SODIUM, |
||||
| 1328 | 26296788 |
US |
35 | 2 |
Drug dose omission by device, Device defective, |
||||
MEDROXYPROGESTERONE ACETATE, |
||||
| 1329 | 26296790 |
US |
||
Drug dose omission by device, Device breakage, |
||||
SOMATROPIN, |
||||
| 1330 | 26296821 |
US |
2 | |
Drug dose omission by device, Syringe issue, Device leakage, |
||||
MEDROXYPROGESTERONE ACETATE, MEDROXYPROGESTERONE ACETATE, |
||||
| 1331 | 26296831 |
US |
16 | 1 |
Device failure, Drug dose omission by device, |
||||
MARSTACIMAB-HNCQ, |
||||
| 1332 | 26296843 |
CL |
2 | |
Drug dose omission by device, Device leakage, Liquid product physical issue, |
||||
SOMATROPIN, |
||||
| 1333 | 26296845 |
EU |
31 | 2 |
Drug dose omission by device, Device leakage, Device occlusion, |
||||
| 1334 | 26297071 |
US |
59 | 2 |
Illness, Device delivery system issue, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 1335 | 26297712 |
US |
12 | 2 |
Device issue, Device leakage, Drug dose omission by device, Off label use, |
||||
SOMATROPIN, |
||||
| 1336 | 26297752 |
US |
16 | 1 |
Drug dose omission by device, Device defective, |
||||
MARSTACIMAB-HNCQ, |
||||
| 1337 | 26297753 |
US |
2 | 1 |
Device use error, Device breakage, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1338 | 26297983 |
US |
||
Drug dose omission by device, Device delivery system issue, Product container seal issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1339 | 26297984 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1340 | 26298006 |
US |
59 | |
Chest pain, Cough, Device delivery system issue, Drug dose omission by device, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, MONTELUKAST, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, LORATADINE, LORATADINE TABLET, |
||||
| 1341 | 26287758 |
US |
68 | 2 |
Vision blurred, Hyperhidrosis, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 1342 | 26287769 |
US |
2 | |
Device issue, Drug dose omission by device, |
||||
INCLISIRAN, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONAZEPAM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GABAPENTIN, HYDRALAZINE HYDROCHLORIDE, |
||||
| 1343 | 26288411 |
US |
51 | 2 |
Periarthritis, Blood glucose increased, Drug dose omission by device, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 1344 | 26288501 |
US |
75 | |
Dyspnoea, Device delivery system issue, Drug dose omission by device, |
||||
LEVALBUTEROL TARTRATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 1345 | 26288522 |
US |
68 | |
Dyspnoea, Drug dose omission by device, Product packaging quantity issue, Off label use, Device delivery system issue, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, |
||||
| 1346 | 26288657 |
US |
80 | |
Dyspnoea, Off label use, Drug dose omission by device, Device malfunction, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 1347 | 26288675 |
US |
1 | |
Device issue, Product administration error, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 1348 | 26288977 |
US |
72 | 2 |
Drug dose omission by device, Device difficult to use, Wrong technique in product usage process, Product knowledge deficit, Incorrect disposal of product, |
||||
EVOLOCUMAB, |
||||
| 1349 | 26289060 |
US |
77 | |
Panic attack, Cough, Device delivery system issue, Drug dose omission by device, Off label use, Device occlusion, |
||||
ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 1350 | 26289268 |
EU |
70 | 1 |
Cellulitis, Peripheral swelling, Pain, Device malfunction, Drug dose omission by device, Device use error, Accidental exposure to product, Infection, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 1351 | 26289679 |
US |
||
Drug dose omission by device, Device leakage, |
||||
LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, LANREOTIDE ACETATE, |
||||
| 1352 | 26289680 |
US |
||
Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1353 | 26289683 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1354 | 26289684 |
US |
||
Drug dose omission by device, Device delivery system issue, Incorrect dose administered by device, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1355 | 26289934 |
US |
67 | |
Cough, Drug dose omission by device, Device delivery system issue, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1356 | 26289951 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1357 | 26290020 |
US |
2 | |
Drug dose omission by device, Device power source issue, |
||||
INTERFERON BETA-1B, |
||||
| 1358 | 26290503 |
US |
77 | 2 |
Drug dose omission by device, Migraine, Device difficult to use, Inappropriate schedule of product administration, |
||||
ERENUMAB-AOOE, |
||||
| 1359 | 26290628 |
|||
Needle issue, Drug dose omission by device, Accidental exposure to product, |
||||
FREMANEZUMAB-VFRM, |
||||
| 1360 | 26291151 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1361 | 26291152 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1362 | 26291153 |
US |
||
Drug dose omission by device, Product delivery mechanism issue, Device malfunction, Product substitution issue, Product communication issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1363 | 26291366 |
US |
2 | |
Device difficult to use, Drug dose omission by device, Accidental exposure to product, Incorrect disposal of product, Exposure via skin contact, |
||||
EVOLOCUMAB, |
||||
| 1364 | 26282527 |
US |
60 | |
Drug dose omission by device, Device delivery system issue, No adverse event, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, |
||||
| 1365 | 26282618 |
US |
85 | |
Dyspnoea, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, CARVEDILOL, FLECAINIDE ACETATE TABLET, FLECAINIDE ACETATE, |
||||
| 1366 | 26282632 |
US |
74 | |
Middle insomnia, Drug dose omission by device, Device malfunction, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1367 | 26282638 |
US |
1 | |
Drug dose omission by device, Incorrect dose administered, Device deployment issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 1368 | 26282734 |
US |
69 | |
Cough, Wheezing, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, METHYLPREDNISOLONE, |
||||
| 1369 | 26282762 |
US |
||
Wheezing, Dyspnoea, Illness, Oropharyngeal pain, Drug dose omission by device, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1370 | 26283073 |
US |
41 | 2 |
Rheumatoid arthritis, Psoriasis, Drug dose omission by device, |
||||
ETANERCEPT, ETANERCEPT, |
||||
| 1371 | 26283074 |
US |
22 | 2 |
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 1372 | 26283872 |
US |
||
Drug dose omission by device, Incorrect dose administered by device, Device delivery system issue, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1373 | 26283891 |
US |
||
Drug dose omission by device, Device delivery system issue, Product packaging quantity issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1374 | 26284227 |
US |
78 | |
Drug dose omission by device, Device malfunction, Device mechanical issue, Device delivery system issue, No adverse event, |
||||
TIOTROPIUM BROMIDE, |
||||
| 1375 | 26284313 |
US |
60 | 2 |
Nausea, Product communication issue, Injury associated with device, Wrong technique in product usage process, Drug dose omission by device, Pain in extremity, Morning sickness, Mobility decreased, |
||||
EVOLOCUMAB, |
||||
| 1376 | 26284342 |
BR |
39 | 2 |
Diabetes mellitus inadequate control, Wrong technique in product usage process, Device loosening, Device leakage, Device failure, Drug dose omission by device, Manufacturing issue, |
||||
INSULIN DEGLUDEC AND LIRAGLUTIDE, |
||||
| 1377 | 26284384 |
US |
1 | |
Drug dose omission by device, Device breakage, Expired device used, |
||||
INTERFERON BETA-1B, |
||||
| 1378 | 26284473 |
US |
54 | 2 |
Drug dose omission by device, Device operational issue, |
||||
ABATACEPT, |
||||
| 1379 | 26284478 |
US |
74 | 2 |
Pneumonia, Fall, Back injury, Device issue, Drug dose omission by device, Product dose omission issue, Expired device used, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, FEXOFENADINE HYDROCHLORIDE, GABAPENTIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, HYDROXYCHLOROQUINE SULFATE, RANOLAZINE, |
||||
| 1380 | 26286511 |
US |
||
Drug dose omission by device, Device delivery system issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MONTELUKAST SODIUM, |
||||
| 1381 | 26286566 |
US |
2 | |
Drug dose omission by device, Device operational issue, |
||||
INTERFERON BETA-1B, |
||||
| 1382 | 26286579 |
US |
2 | |
Drug dose omission by device, Device operational issue, |
||||
INTERFERON BETA-1B, |
||||
| 1383 | 26286599 |
KR |
10 | 1 |
Drug dose omission by device, Device information output issue, |
||||
SOMATROPIN, |
||||
| 1384 | 26286604 |
US |
41 | 2 |
Device use error, Device breakage, Device issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1385 | 26286605 |
AR |
15 | 2 |
Device mechanical issue, Device information output issue, Device delivery system issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1386 | 26286606 |
US |
70 | 2 |
Drug dose omission by device, Device mechanical issue, Device delivery system issue, |
||||
SOMATROPIN, |
||||
| 1387 | 26286608 |
GB |
69 | 1 |
Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1388 | 26286622 |
KR |
10 | 1 |
Device power source issue, Device information output issue, Drug dose omission by device, |
||||
SOMATROPIN, |
||||
| 1389 | 26286634 |
EU |
11 | 1 |
Drug dose omission by device, Device use error, Device material issue, |
||||
SOMATROPIN, |
||||
| 1390 | 26287199 |
US |
29 | 2 |
Injection site pain, Injection site bruising, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 1391 | 26276855 |
US |
||
Drug dose omission by device, Device delivery system issue, Device mechanical issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1392 | 26276898 |
US |
79 | 2 |
Diabetes mellitus inadequate control, Drug dose omission by device, Device issue, Product dispensing issue, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 1393 | 26276978 |
US |
60 | 2 |
Device difficult to use, Device use error, Accidental exposure to product, Drug dose omission by device, Injection site erythema, Sinus headache, Exposure via skin contact, |
||||
ERENUMAB-AOOE, UBROGEPANT, |
||||
| 1394 | 26276979 |
US |
71 | 2 |
Device difficult to use, Drug dose omission by device, Headache, |
||||
ERENUMAB-AOOE, |
||||
| 1395 | 26277046 |
US |
28 | 2 |
Injection site pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 1396 | 26277448 |
US |
||
Insomnia, Dyspnoea, Drug dose omission by device, Product packaging issue, Product container issue, Product expiration date issue, |
||||
ALBUTEROL SULFATE, |
||||
| 1397 | 26278204 |
US |
1 | |
Accidental exposure to product, Device delivery system issue, Drug dose omission by device, |
||||
SECUKINUMAB, |
||||
| 1398 | 26278266 |
EU |
41 | 2 |
Scratch, Needle issue, Drug dose omission by device, |
||||
OFATUMUMAB, |
||||
| 1399 | 26278411 |
US |
||
Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1400 | 26278602 |
US |
2 | |
Device delivery system issue, Product use issue, Wrong technique in product usage process, Drug dose omission by device, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28